THERAPEUTIC CLASS
Risk of Hospitalization for Cardiovascular Events with b-Blockers in Hypertensive Patients: A Retrospective Cohort Study
Incident nebivolol, atenolol, or metoprolol monotherapy users with hypertension were identified using US claims data
(2007–2014). The first b-blocker claim on/after 1/1/2008 defined the index drug/date. Hypertensive patients without pre-index cardiovascular history were followed until index drug discontinuation ([90 day supply gap), use of other b-blockers, or end of continuous plan enrollment
No other version available